#immune design

[alphst]

Immune Design stock more than triples as it gets acquired by Merck

Immune Design stock more than triples as it gets acquired by Merck

Merck (MRK) announced that it will acquire immunotherapy developer Immune Design (IMDZ) for $5.85 per share in cash for an approximate value of $300 million. Shares of Immune Design skyrocketed more than 300% in the pre-market trading, while Merck stock was trading flat.

(This story will be developed shortly)

  We’re on Apple News! Follow us to receive the latest stock market, earnings, and…

View On WordPress

[bidhuan]

Perusahaan Immune Design Kembangkan Personal Imunoterapi Kanker Neoantigen

Perusahaan Immune Design Kembangkan Personal Imunoterapi Kanker Neoantigen

Perusahaan Immune Design Kembangkan Personal Imunoterapi Kanker Neoantigen. Immune Design, sebuah perusahaan imunoterapi tahap klinis yang berfokus pada onkologi, dan Gritstone Oncology, sebuah perusahaan imunoterapi kanker dengan terapi kanker secara personal, mengumumkan kolaborasi klinis untuk pengembangan terapi baru immunoterapi personal dengan menggabungkan teknologi terkemuka kedua…

View On WordPress